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Antibiotic Resistance Solutions Initiative
$264M: A Comprehensive Response
The problem
Antibiotic resistance, when bacteria don’t respond to the drugs 
designed to kill them, threatens to return us to the time when 
simple infections were often fatal. To address this threat, CDC and 
public health partners must fully implement the National Strategy 
for Combating Antibiotic-Resistant Bacteria. 
Estimated minimum number of illnesses and 
deaths caused by antibiotic resistance:
At least 2,049,442 illnesses
 23,000 deaths
The action
The national strategy identifies five core actions:
uu Slow the Development of Resistant Bacteria and Prevent  
the Spread of Resistant Infections 
uu Strengthen National One-Health Surveillance Efforts to 
Combat Resistance 
uu Advance Development and Use of Rapid and Innovative 
Diagnostic Tests for Identification and Characterization  
of Resistant Bacteria 
uu Accelerate Basic and Applied Research and Development  
for New Antibiotics, Other Therapeutics, and Vaccines
uu Improve International Collaboration and Capacities for 
Antibiotic Resistance Prevention, Surveillance, Control,  
and Antibiotic Research and Development  
Antibiotic Resistance Threats Impact:
• Healthcare
• Food/Farms
• Community
• The World
The results
The FY16 AR Solution Initiative fully implements the National 
Strategy for Combating Antibiotic-Resistant Bacteria. 
üü Comprehensive Tracking
üü Rapid Detection
üü Faster Outbreak Response
üü Insights for Research Innovation
üü Better Patient Care
üü Improved Prescribing
üü 10x More Susceptibility Testing
üü Nationwide Implementation of CDC Core Elements  
of Hospital Antibiotic Stewardship
üü Global Partnerships for Prevention and Detection
Anticipated % Reduction RATE
Rates down:
Healthcare-CRE: 60%
Overall C. difficile: 50%
Bloodstream MRSA: 50%
Healthcare MDR Pseudomonas: 35%
MDR Salmonella: 25%
Invasive Pneumococcal (Pediatric and Geriatric): 25%
MDR Tuberculosis 15%
Maintain less than:
MDR Gonorrhea 2%
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The details
Stop Spread; Protect People 
Action in every state 
uu Establish State AR Prevention Programs (“Protect Programs”), groups of 
healthcare facilities in communities around the country that work together to 
better track outbreaks, improve prescribing, and prevent infections  
uu Detect and respond rapidly to reduce spread of multidrug-resistant 
gonorrhea (GC) and better treatment of GC
uu Identify critical new interventions against multidrug-resistant tuberculosis 
(TB) and expand pre-migration TB screening beyond immigrants and refugees
uu Support development of next generation rapid susceptibility tests for  
drug-resistant pathogens 
uu Identify new ways to prevent human infections caused by resistant bacteria (such as Salmonella) from food animals  
using the National Antimicrobial Resistance Monitoring System (NARMS)
Track Superbugs; Measure Impact  
Accelerate outbreak detection and prevention innovation 
uu New Detect Network of AR Regional Labs to improve response to outbreaks of urgent, serious, or concerning threats; 
know faster which antibiotics work; and use cutting edge methods to track and get ahead of spread  
uu New AR Isolate Bank to provide a complete collection of current resistant threats; help keep pace with mutations; and 
provide information for FDA-approval of products and for companies/researchers’ new tests and antibiotics
uu Measure impact of antibiotics on human microbiome to learn if a healthy microbiome protects people and to learn if 
antibiotics given to infants and elderly lead to health problems or higher risk of drug-resistant infection
uu Double number of CDC’s Emerging Infections Program (EIP) sites to expand tracking to urgent and serious threats; 
track evolving AR threats better; and improve understanding of who is at risk 
uu Enhance global partnerships for prevention and detection to combat AR internationally
Track and Improve Prescribing 
Improve antibiotic use and reduce antibiotic resistance  
uu Provide real-time data about antibiotic use and trends in healthcare in 
specific facilities and across regions using the National Healthcare Safety Network 
(NHSN); set the standard for how facilities, communities, states, and the nation 
can improve antibiotic use and reduce resistance
uu Improve antibiotic prescribing practices in healthcare (antibiotic 
stewardship) by ensuring all hospitals have effective stewardship programs and 
evaluating state-to-state variations in antibiotic use to improve prescribing outside of hospitals
uu Provide real-time data about antibiotic use and trends for outpatient care to better understand prescribing practices 
and set national goals for improving antibiotic use
uu Measure the impact of antibiotic use on human and animal health and greatly scale up rapid detection of AR 
infections commonly transmitted through food to humans by collaborating with FDA and USDA to expand the National 
Antimicrobial Resistance Monitoring System (NARMS)
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